Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice

International Immunopharmacology

Volumn 15, Issue 2, 2013, Pages 424-432

  Kim, Chang Hyun ^a   Choi, Yun Seok ^a   Cheong, Kyung Ah ^a   Lee, Ai Young ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Atopic dermatitis; Combination therapy; Cyclosporine A; Glucosamine; NC Nga mice

Indexed keywords

CYCLOSPORIN A; CYTOKERATIN 10; CYTOKERATIN 14; EOTAXIN; FILAGGRIN; GLUCOSAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INVOLUCRIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CD4+ CD25+ T LYMPHOCYTE; CELL INFILTRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LOW DRUG DOSE; MALE; MAST CELL; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCORING SYSTEM;

ANIMALS; ANTIGENS, CD4; ANTIGENS, DERMATOPHAGOIDES; CELLS, CULTURED; CYCLOSPORINE; CYTOKINES; DERMATITIS, ATOPIC; DERMATOPHAGOIDES FARINAE; DRUG DOSAGE CALCULATIONS; DRUG THERAPY, COMBINATION; EOSINOPHILS; GLUCOSAMINE; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERMEDIATE FILAMENT PROTEINS; KERATINS; MALE; MAST CELLS; MICE; MICE, INBRED STRAINS; SKIN; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE;

EID: 84873427654     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.01.005     Document Type: Article

References (40)

1. C. Hoare, A. Li Wan Po, and H. Williams Systematic review of treatments for atopic eczema Health Technol Assess 4 2000 1 191
2. D.Y.M. Leung, and T. Bieber Atopic dermatitis Lancet 361 2003 151 160
3. J.M. Spergel, E. Mizoguchi, H. Oettgen, A.K. Bhan, and R.S. Geha Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis J Clin Invest 103 1999 1103 1111
4. M. Miraglia del Giudice, F. Decimo, S. Leonardi, N. Maioello, R. Amelio, and A. Capasso Immune dysregulation in atopic dermatitis Allergy Asthma Proc 27 2006 451 455
5. R. Wolf, and D. Wolf Abnormal epidermal barrier in the pathogenesis of atopic dermatitis Clin Dermatol 30 2012 329 334
6. M. Uehara, R. Izukura, and T. Sawai Blood eosinophilia in atopic dermatitis Clin Exp Dermatol 15 1990 264 266
7. E.A. James, and W.W. Kwok Autoreactive CD4(+) T cells in patients with atopic dermatitis J Allergy Clin Immunol 128 2011 100 101
8. M. Akdis, K. Blaser, and C.A. Akdis T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases J Allergy Clin Immunol 116 2005 961 968
9. J. Inoue, and Y. Aramaki Suppression of skin lesions by transdermal application of CpG-oligodeoxynucleotides in NC/Nga mice, a model of human atopic dermatitis J Immunol 178 2007 584 591
10. L. Forchhammer, M. Thorn, O. Met, M. Gad, M.S. Weidner, and M.H. Claesson Immunobiological effects of glucosamine in vitro Scand J Immunol 58 2003 404 411
11. C.H. Kim, K.A. Cheong, C.D. Park, and A.Y. Lee Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development Scand J Immunol 73 2011 536 545
12. S. Guglielmetti, J.K. Dart, and V. Calder Atopic keratoconjunctivitis and atopic dermatitis Curr Opin Allergy Clin Immunol 10 2010 478 485
13. C.A. Akdis, M. Akdis, T. Bieber, C. Bindslev-Jensen, M. Boguniewicz, and P. Eigenmann Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report J Allergy Clin Immunol 118 2006 152 169
14. E. Campione, E.J. Paternò, L. Diluvio, L. Bianchi, G. Giorgetti, and S. Chimenti Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B Acta Derm Venereol 88 2008 74 75
15. D.H. Nahm, and M.E. Kim Treatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin Yonsei Med J 53 2012 158 163
16. H. Jin, R. He, M. Oyoshi, and R.S. Geha Animal models of atopic dermatitis J Invest Dermatol 129 2009 31 40
17. C.H. Kim, K.A. Cheong, C.D. Park, and A.Y. Lee Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice Scand J Immunol 75 2012 471 478
18. H. Suto, H. Matsuda, K. Mitsuishi, K. Hira, T. Uchida, and T. Unno NC/Nga mice: a mouse model for atopic dermatitis Int Arch Allergy Immunol 120 1999 70 75
19. L.S. Fonacier, S.C. Dreskin, and D.Y. Leung Allergic skin diseases J Allergy Clin Immunol 125 2 Suppl. 2 2010 S138 S149
20. C.M. Gelbard, and A.A. Hebert New and emerging trends in the treatment of atopic dermatitis Patient Prefer Adherence 2 2008 387 392
21. Y. Kubota, K. Yoneda, K. Nakai, J. Katsuura, T. Moriue, and Y. Matsuoka Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study J Am Acad Dermatol 60 2009 212 217
22. T. Nakahara, T. Koga, S. Fukagawa, H. Uchi, and M. Furue Intermittent topical corticosteroid/tacrolimus sequential therapy improves lichenification and chronic papules more efficiently than intermittent topical corticosteroid/emollient sequential therapy in patients with atopic dermatitis J Dermatol 31 2004 524 528
23. D. Vercelli, and R.S. Geha Regulation of isotype switching Curr Opin Immunol 4 1992 794 797
24. H. Matsuda, N. Watanabe, G.P. Geba, J. Sperl, M. Tsudzuki, and J. Hiroi Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice Int Immunol 9 1997 461 466
25. T. Nakatani, Y. Kaburagi, Y. Shimada, M. Inaoki, K. Takehara, and N. Mukaida CCR4 memory CD4 + T lymphocytes are increased in peripheral blood and lesional skin from patients with atopic dermatitis J Allergy Clin Immunol 107 2001 353 358
26. W. Ma, P.J. Bryce, A.A. Humbles, D. Laouini, A. Yalcindag, and H. Alenius CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation J Clin Invest 109 2002 621 628
27. Y.J. Liu Thymic stromal lymphopoietin: master switch for allergic inflammation J Exp Med 203 2006 269 273
28. Y.J. Liu Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation J Allergy Clin Immunol 120 2007 238 244
29. M. Stassen, H. Jonuleit, C. Müller, M. Klein, C. Richter, and T. Bopp Differential regulatory capacity of CD25 + T regulatory cells and preactivated CD25 + T regulatory cells on development, functional activation, and proliferation of Th2 cells J Immunol 173 2004 267 274
30. M. Larché Regulatory T, cells in allergy and asthma Chest 132 2007 1007 1014
31. C. Brandt, V. Pavlovic, A. Radbruch, M. Worm, and R. Baumgrass Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis Allergy 64 2009 1588 1596
32. A. Kubo, K. Nagao, and M. Amagai Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases J Clin Invest 122 2012 440 447
33. S.J. Galli, S. Nakae, and M. Tsai Mast cells in the development of adaptive immune responses Nat Immunol 6 2005 135 142
34. M.D. Howell, B.E. Kim, P. Gao, A.V. Grant, M. Boguniewicz, and A. DeBenedetto Cytokine modulation of atopic dermatitis filaggrin skin expression J Allergy Clin Immunol 124 3 Suppl. 2 2009 R7 R12
35. B.E. Kim, D.Y. Leung, M. Boguniewicz, and M.D. Howell Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6 Clin Immunol 126 2008 332 337
36. H. Wakita, Y. Yamamoto, and F. Furukawa Aberrant suprabasal P-cadherin expression in acanthotic but not psoriatic thickened epidermis Arch Dermatol Res 295 Suppl. 1 2003 S71 S74
37. S. Theerawatanasirikul, A. Sailasuta, R. Thanawongnuwech, and G. Suriyaphol Alterations of keratins, involucrin and filaggrin gene expression in canine atopic dermatitis Res Vet Sci 93 2012 1287 1292
38. A. Mantel, A.B. Carpenter-Mendini, J.B. Vanbuskirk, A. De Benedetto, L.A. Beck, and A.P. Pentland Aldo-keto reductase 1C3 is expressed in differentiated human epidermis, affects keratinocyte differentiation, and is upregulated in atopic dermatitis J Invest Dermatol 132 2012 1103 1110
39. Z.D. Draelos Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas Curr Med Res Opin 24 2008 985 994
40. J.M. Jensen, S. Pfeiffer, M. Witt, M. Bräutigam, C. Neumann, and M. Weichenthal Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis J Allergy Clin Immunol 123 2009 1124 1133